Solving the Problem of Insolubility: Part III
Exploring new applications for KinetiSol and the evolving role of CDMOs in bringing the next generation of complex molecules to patients
Austin Px CEO Elizabeth Hickman and CSO Dave Miller discussed KinetiSol's innovative approach to drug delivery that leverages plastics recycling technology. This method enhances solubility for previously undeliverable molecules, opening pathways for oral and parenteral administration. Recent collaborations and awards support their mission, while the company addresses challenges like rising expectations and development costs in a complex industry. The advent of machine learning is democratizing drug discovery, enabling smaller entities to contribute significantly, with CDMOs playing a crucial role in bridging innovation to market.
1. KinetiSol improves drug delivery by dissolving poorly soluble molecules. 2. Technology inspired by plastics recycling. 3. Recent studies show potential for parenteral and inhalation delivery. 4. KinetiSol won the Advancing Pharmacy Research Award. 5. Innovation is focusing on overcoming traditional drug development challenges. 6. Machine learning democratizes drug discovery, allowing smaller entities to contribute. 7. CDMOs are crucial for translating innovations into patient treatments.
